Dermatomyositis
📧 Sign up to get email alerts when something new happens for Dermatomyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-25Clinical Trial Results: A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) [Phase 2]
Phase 2 proof-of-concept study evaluating the efficacy and safety of Daxdilimab in dermatomyositis and anti-synthetase inflammatory myositis…
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the efficacy and safety of Efgartigimod PH20 SC in adults with active idiopathic inflammatory myopathy has comp…
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis [Phase 3]
Phase 3 trial update for brepocitinib in adults with dermatomyositis indicates ongoing investigation of efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) [Phase 2, Phase 3]
A Phase 2/3 clinical trial update reports on safety and efficacy of ULSC for reducing disease severity and enabling steroid tapering in Derm…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) [Phase 2]
Phase 2 clinical trial evaluating fatty acid supplementation for Dermatomyositis and Juvenile Dermatomyositis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Environmental Risk Factors for Myositis in Military Personnel
A completed NIEHS-sponsored clinical study evaluated environmental risk factors for myositis in military personnel, including dermatomyositi…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Adult and Juvenile Myositis
This entry reports that a NIEHS-sponsored clinical trial investigating adult and juvenile myositis is currently recruiting for dermatomyosit…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy [Phase 2, Phase 3]
An open-label Phase 2/3 trial to evaluate the safety and efficacy of CABA-201 in active idiopathic inflammatory myopathy and related juvenil…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] [Phase 3]
Pfizer is conducting a Phase 3 trial of PF-06823859 to study its effects in people with active idiopathic inflammatory myopathies, specifica…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy [Phase 3]
A Phase 3 trial evaluating the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO [Phase 1]
Phase 1 trial evaluating nivolumab in patients with autoimmune disorders and advanced cancers; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) [Phase 3]
A Phase 3 trial to evaluate the efficacy and safety of subcutaneous anifrolumab added to standard of care versus placebo with standard of ca…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Environmental Risk Factors for the Anti-synthetase Syndrome
This NIEHS-sponsored clinical trial investigates environmental risk factors for anti-synthetase syndrome, enrolling patients with inflammato…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical Parameters
A clinical trial update on building a clinico-imaging diagnostic model for Dermatomyositis with interstitial lung disease using PET/CT featu…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study [Phase 2]
Phase 2 trial update for emapalumab in rapidly progressive interstitial lung disease associated with dermatomyositis; the study is not yet r…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies [Phase 3]
This is a Phase 3 clinical trial investigating how the study drug Dazukibart works in people with Dermatomyositis and Polymyositis, with rec…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) [Phase 1]
Phase 1b long-term extension trial of RAY121 in multiple immunological diseases is currently enrolling by invitation, expanding early-phase …
-
CLINICAL_TRIALS other · 2026-04-02Clinical Trial Update: Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) [Phase 1]
Chugai Pharmaceutical’s RAY121 is being studied in a Phase 1b trial (RAINBOW) across several immunological diseases, and the study is curren…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies [NA]
A completed clinical trial evaluating the diagnostic accuracy of whole-body magnetic resonance imaging for detecting inflammatory myopathies…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) [Phase 2, Phase 3]
The sponsor reports an ongoing Phase 2/3 trial assessing the safety and efficacy of ULSC in reducing disease severity and aiding steroid tap…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
This entry reports a recruiting clinical trial at the University of Pennsylvania evaluating the responsiveness of dermatomyositis using the …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties [NA]
This completed clinical trial evaluated muscle function and the effects of repetitive task training in patients with inflammatory myopathies…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Add-on Intravenous Immunoglobulins in Early Myositis [Phase 2, Phase 3]
A Phase 2/Phase 3 add-on intravenous immunoglobulin study for early inflammatory myopathies (myositis) is active but not currently recruitin…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
This Clinical Trial Update notes that studies on the natural history and pathogenesis of autoimmune and connective tissue diseases have comp…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Rheumatology Patient Registry and Biorepository
This Clinical Trial Update describes a Yale University-led rheumatology patient registry and biorepository that is currently recruiting to c…